Search Within

Charlotte Eielson Ariyan

  1. "Biostatistics Service"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (16)
  3. Miscellaneous (1)
  4. Research Letter (1)
Groups
  1. Biostatistics Service (37)
  2. Epidemiology and Biostatistics (37)
  3. Melanoma Disease Management Team (37)
  4. Surgery (37)
  5. Survivorship Research (28)
  6. Department of Medicine (27)

More Groups

People
  1. Katherine Panageas (26)
  2. Daniel Coit (24)
  3. Mary Brady (22)
  4. Jedd Wolchok (12)
  5. Michael Postow (12)
  6. Alexander Shoushtari (8)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2021 (4)
  4. 2020 (6)
  5. 2019 (3)
  6. 2018 (4)

More Years

Publications
  1. Annals of Surgical Oncology (17)
  2. Journal of Clinical Oncology (8)
  3. Cancer (1)
  4. Cancer Discovery (1)
  5. Cancer Immunology Research (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Springer (17)
  2. American Society of Clinical Oncology (8)
  3. American Association for Cancer Research (3)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (2)
  6. American Medical Association (1)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Journal Article

    Barker, C. A.; D'Angelo, S. P.; Wasilewski, G.; Steckler, A. M.; Lian, M.; Zhang, Z.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Assessment of frailty can guide decision making for utilization of sentinel lymph node biopsy in patients with thick melanoma
    Miscellaneous

    Sharma, A. S.; Flynn, J. R.; Panageas, K. S.; Shahrokni, A.; Tin, A. L.; Bello, D. M.; Ariyan, C. E.; Brady, M. S.; Coit, D. G.; Bartlett, E. K.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Assessment of frailty can guide decision making for utilization of sentinel lymph node biopsy in patients with thick melanoma
    Journal Article

    Sharma, A. S.; Flynn, J. R.; Panageas, K. S.; Shahrokni, A.; Tin, A. L.; Bello, D. M.; Ariyan, C. E.; Brady, M. S.; Coit, D. G.; Bartlett, E. K.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J.; Do, R.; Capanu, M.; Zamarin, D.; Saltz, L.; Ariyan, C.; more...
    Pancreas (2020)

    Fulltext@MSK | Save
  • Response to checkpoint blockade and survival in patients with stage III melanoma
    Meeting Abstract

    Theriot, J.; Bello, D.; Lobaugh, S.; Bartlett, E. K.; Betof, A.; Shoushtari, A.; Postow, M.; Callahan, M.; Brady, M. S.; Wong, R.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Survival outcomes after metastasectomy in melanoma patients categorized by response to checkpoint blockade
    Journal Article

    Bello, D. M.; Panageas, K. S.; Hollmann, T.; Shoushtari, A. N.; Momtaz, P.; Chapman, P. B.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save